Ndfip1 regulates itch ligase activity and airway inflammation via UbcH7

Journal of Immunology

Volumn 194, Issue 5, 2015, Pages 2160-2167

  Kathania, Mahesh ^a   Zeng, Minghui ^a   Yadav, Viveka Nand ^b   Moghaddam, Seyed Javad ^c   Yang, Baoli ^d   Venuprasad, K ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CYTOKINE; PROLINE; PROTEIN ITCH; PROTEIN NDFIP1; PROTEIN UBCH7; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TYROSINE; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; ITCH PROTEIN, MOUSE; MAP KINASE KINASE KINASE 7; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NDFIP1 PROTEIN, MOUSE; PROTEIN BINDING; UBE2L3 PROTEIN, MOUSE; UBIQUITIN CONJUGATING ENZYME;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME RECONSTITUTION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; UBIQUITINATION; ANIMAL; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HAEMOPHILUS INFECTION; HEK293 CELL LINE; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LENTIVIRINAE; METABOLISM; MICROBIOLOGY; PROTEIN DOMAIN; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; GENE EXPRESSION REGULATION; GENETIC VECTORS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HEK293 CELLS; HUMANS; INFLAMMATION; LENTIVIRUS; MAP KINASE KINASE KINASES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84924388765     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402742     Document Type: Article

References (42)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Grivennikov, S. I., F. R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell 140: 883-899.
3. Bhoj, V. G., and Z. J. Chen. 2009. Ubiquitylation in innate and adaptive immunity. Nature 458: 430-437.
4. Venuprasad,K., C.Yang,Y. Shao, D. Demydenko,Y. Harada,M. S. Jeon, andY.C. Liu. 2006. Immune regulation by ubiquitin conjugation. Adv. Exp. Med. Biol. 584: 207-217.
5. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70: 503-533.
6. Perry, W. L., C. M. Hustad, D. A. Swing, T. N. O'Sullivan, N. A. Jenkins, and N. G. Copeland. 1998. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat. Genet. 18: 143-146.
7. Fang, D., C. Elly, B. Gao, N. Fang, Y. Altman, C. Joazeiro, T. Hunter, N. Copeland, N. Jenkins, and Y. C. Liu. 2002. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol. 3: 281-287.
8. Lohr, N. J., J. P. Molleston, K. A. Strauss, W. Torres-Martinez, E. A. Sherman, R. H. Squires, N. L. Rider, K. R. Chikwava, O.W. Cummings, D. H. Morton, and E. G. Puffenberger. 2010. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am. J. Hum. Genet. 86: 447-453.
9. Jolliffe, C. N., K. F. Harvey, B. P. Haines, G. Parasivam, and S. Kumar. 2000. Identification of multiple proteins expressed in murine embryos as binding partners for the WW domains of the ubiquitin-protein ligase Nedd4. Biochem. J. 351: 557-565.
10. Harvey, K. F., L. M. Shearwin-Whyatt, A. Fotia, R. G. Parton, and S. Kumar. 2002. N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein. J. Biol. Chem. 277: 9307-9317.
11. Oliver, P. M., X. Cao, G. S. Worthen, P. Shi, N. Briones, M. MacLeod, J. White, P. Kirby, J. Kappler, P. Marrack, and B. Yang. 2006. Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation. Immunity 25: 929-940.
12. Sethi, S., and T. F. Murphy. 2008. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359: 2355-2365.
13. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98: 8774-8779.
14. Ahmed, N., M. Zeng, I. Sinha, L. Polin, W. Z. Wei, C. Rathinam, R. Flavell, R. Massoumi, and K. Venuprasad. 2011. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation. Nat. Immunol. 12: 1176-1183.
15. Mund, T., and H. R. Pelham. 2009. Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins. EMBO Rep. 10: 501-507.
16. Maine, G. N., H. Li, I. W. Zaidi, V. Basrur, K. S. Elenitoba-Johnson, and E. Burstein. 2010. A bimolecular affinity purification method under denaturing conditions for rapid isolation of a ubiquitinated protein for mass spectrometry analysis. Nat. Protoc. 5: 1447-1459.
17. Nesvizhskii, A. I., A. Keller, E. Kolker, and R. Aebersold. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75: 4646-4658.
18. Moghaddam, S. J., C. G. Clement, M. M. De la Garza, X. Zou, E. L. Travis, H. W. Young, C. M. Evans, M. J. Tuvim, and B. F. Dickey. 2008. Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am. J. Respir. Cell Mol. Biol. 38: 629-638.
19. Bellmeyer, A., J. M. Martino, N. S. Chandel, G. R. Scott Budinger, D. A. Dean, and G. M. Mutlu. 2007. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am. J. Respir. Crit. Care Med. 175: 587-594.
20. Lamb, A., X. D. Yang, Y. H. Tsang, J. D. Li, H. Higashi, M. Hatakeyama, R. M. Peek, S. R. Blanke, and L. F. Chen. 2009. Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep. 10: 1242-1249.
21. Liang, L., Y. Fan, J. Cheng, D. Cheng, Y. Zhao, B. Cao, L. Ma, L. An, W. Jia, X. Su, et al. 2013. TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation. Cell. Signal. 25: 247-254.
22. Sakurai, H. 2012. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol. Sci. 33: 522-530.
23. Fan, Y., Y. Yu, R. Mao, H. Zhang, and J. Yang. 2011. TAK1 Lys-158 but not Lys-209 is required for IL-1β-induced Lys63-linked TAK1 polyubiquitination and IKK/NF-κB activation. Cell. Signal. 23: 660-665.
24. Fan, Y., Y. Yu, Y. Shi, W. Sun, M. Xie, N. Ge, R. Mao, A. Chang, G. Xu, M. D. Schneider, et al. 2010. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1 beta-induced IKK/NF-kappaB and JNK/AP-1 activation. J. Biol. Chem. 285: 5347-5360.
25. Berenson, C. S., C. T. Wrona, L. J. Grove, J. Maloney, M. A. Garlipp, P. K. Wallace, C. C. Stewart, and S. Sethi. 2006. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 174: 31-40.
26. Caramori, G., I. M. Adcock, A. Di Stefano, and K. F. Chung. 2014. Cytokine inhibition in the treatment of COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 9: 397-412.
27. Rotta Detto Loria, J., K. Rohmann, D. Droemann, P. Kujath, J. Rupp, T. Goldmann, and K. Dalhoff. 2013. Nontypeable Haemophilus Influenzae Infection Upregulates the NLRP3 Inflammasome and Leads to Caspase-1-Dependent Secretion of Interleukin-1β - A Possible Pathway of Exacerbations in COPD. PLoS ONE 8: e66818.
28. Gaschler, G. J., M. Skrtic, C. C. Zavitz, M. Lindahl, P. O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stämpfli. 2009. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am. J. Respir. Crit. Care Med. 179: 666-675.
29. Erridge, C., S. Kennedy, C. M. Spickett, and D. J. Webb. 2008. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. J. Biol. Chem. 283: 24748-24759.
30. Li, D., H. Lei, Z. Li, H. Li, Y. Wang, and Y. Lai. 2013. A novel lipopeptide from skin commensal activates TLR2/CD36-p38 MAPK signaling to increase antibacterial defense against bacterial infection. PLoS ONE 8: e58288.
31. Ninomiya-Tsuji, J., T. Kajino, K. Ono, T. Ohtomo, M. Matsumoto, M. Shiina, M. Mihara, M. Tsuchiya, and K. Matsumoto. 2003. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278: 18485-18490.
32. Melino, G., E. Gallagher, R. I. Aqeilan, R. Knight, A. Peschiaroli, M. Rossi, F. Scialpi, M. Malatesta, L. Zocchi, G. Browne, et al. 2008. Itch: a HECT-type E3 ligase regulating immunity, skin and cancer. Cell Death Differ. 15: 1103-1112.
33. Gallagher, E., M. Gao, Y. C. Liu, and M. Karin. 2006. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl. Acad. Sci. USA 103: 1717-1722.
34. Raimondo, D., A. Giorgetti, F. Bernassola, G. Melino, and A. Tramontano. 2008. Modelling and molecular dynamics of the interaction between the E3 ubiquitin ligase Itch and the E2 UbcH7. Biochem. Pharmacol. 76: 1620-1627.
35. Zhang, P., C. Wang, K. Gao, D. Wang, J. Mao, J. An, C. Xu, D. Wu, H. Yu, J. O. Liu, and L. Yu. 2010. The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation. J. Biol. Chem. 285: 8869-8879.
36. Rossi, M., B. Rotblat, K. Ansell, I. Amelio, M. Caraglia, G. Misso, F. Bernassola, C. N. Cavasotto, R. A. Knight, A. Ciechanover, and G. Melino. 2014. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. Cell Death Dis. 5: e1203.
37. Venuprasad, K. 2010. Cbl-b and itch: key regulators of peripheral T-cell tolerance. Cancer Res. 70: 3009-3012.
38. Kapur, N., K. Grimwood, I. B. Masters, P. S. Morris, and A. B. Chang. 2012. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr. Pulmonol. 47: 300-307.
39. King, P. T., S. R. Holdsworth, N. J. Freezer, E. Villanueva, and P. W. Holmes. 2007. Microbiologic follow-up study in adult bronchiectasis. Respir. Med. 101: 1633-1638.
40. Moghaddam, S. J., C. E. Ochoa, S. Sethi, and B. F. Dickey. 2011. Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int. J. Chron. Obstruct. Pulmon. Dis. 6: 113-123.
41. Chen, R., J. H. Lim, H. Jono, X. X. Gu, Y. S. Kim, C. B. Basbaum, T. F. Murphy, and J. D. Li. 2004. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem. Biophys. Res. Commun. 324: 1087-1094.
42. Kee, Y., and J. M. Huibregtse. 2007. Regulation of catalytic activities of HECT ubiquitin ligases. Biochem. Biophys. Res. Commun. 354: 329-333.